Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia
- PMID: 25540872
- PMCID: PMC4300055
- DOI: 10.1186/s12879-014-0733-7
Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia
Abstract
Background: Colorectal cancer (CRC) is the 3rd most common cancer worldwide and the Czech Republic has the 6th highest incidence of CRC worldwide. Large intestinal microbiota play in its etiopathogenesis important role. Bacteriocins are proteins, produced by bacteria from the Enterobacteriaceae family. The aim of our prospective study was to assess the colonization of large intestinal mucosa by Escherichia coli strains and to investigate their bacteriocin production.
Methods: A total of 30 consecutive patients with colorectal adenoma, CRA (17 men, 13 women, aged 39-79, mean age 63 ± 9), 30 patients with CRC (23 men, 7 women, aged 38-86, mean age 67 ± 11) and 20 healthy controls (9 men, 11 women, age 23-84, mean age 55 ± 15) were enrolled into prospective study. Mucosal biopsies were taken in the caecum, transverse colon and rectum during pancolonoscopy. Microbiological culture, isolation and identification of bacteria followed. Bacteriocin production was assessed by growth inhibition of indicator strains E. coli K12-Row, E. coli C6 (phi), and Shigella sonnei 17. Identification of bacteriocin-encoding determinants and E. coli phylogroups was performed using PCR methods.
Results: A total of 622 strains were isolated and further investigated. A significantly higher frequency of simultaneous production of colicins and microcins was revealed in the group of patients with CRC, when compared to patients with CRA, p = 0.031. A significantly higher frequency of E. coli phylogroup D was found in patients with CRC, when compared to controls, p = 0.044. A significantly higher prevalence of bacteriocinogeny was confirmed in patients with advanced adenoma when compared to patients with non-advanced adenoma, p = 0.010. Increasing bacteriocinogeny was associated with an increasing stage of CRC (assessed according to TNM classification). Either E. coli phylogroup B2 or E. coli phylogroup D were isolated in biopsies of patients with right-sided CRC. A statistically higher incidence of E. coli phylogroup B2 was found in patients with right-sided CRC when compared to patients with left-sided CRC, p = 0.028.
Conclusions: Large intestinal mucosa of patients with more advanced colorectal neoplasia is colonized with more virulent strains of E. coli and higher production of bacteriocins is observed in these patients when compared to those with less advanced colorectal neoplasia.
Similar articles
-
Microcin determinants are associated with B2 phylogroup of human fecal Escherichia coli isolates.Microbiologyopen. 2016 Jun;5(3):490-8. doi: 10.1002/mbo3.345. Epub 2016 Mar 14. Microbiologyopen. 2016. PMID: 26987297 Free PMC article.
-
Bacteriocin production by mucosal bacteria in current and previous colorectal neoplasia.BMC Cancer. 2020 Jan 16;20(1):39. doi: 10.1186/s12885-020-6512-5. BMC Cancer. 2020. PMID: 31948419 Free PMC article.
-
Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.World J Gastroenterol. 2011 Feb 7;17(5):609-17. doi: 10.3748/wjg.v17.i5.609. World J Gastroenterol. 2011. PMID: 21350709 Free PMC article.
-
Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.Expert Rev Gastroenterol Hepatol. 2015 May;9(5):651-7. doi: 10.1586/17474124.2015.1001745. Epub 2015 Jan 12. Expert Rev Gastroenterol Hepatol. 2015. PMID: 25582922 Review.
-
Intestinal microbiota and its association with colon cancer and red/processed meat consumption.J Gastroenterol Hepatol. 2021 Jan;36(1):75-88. doi: 10.1111/jgh.15042. Epub 2020 Apr 3. J Gastroenterol Hepatol. 2021. PMID: 32198788 Review.
Cited by
-
Bacteriocins: potentials and prospects in health and agrifood systems.Arch Microbiol. 2024 Apr 25;206(5):233. doi: 10.1007/s00203-024-03948-y. Arch Microbiol. 2024. PMID: 38662051 Free PMC article. Review.
-
Garlic consumption and colorectal cancer risk in US adults: a large prospective cohort study.Front Nutr. 2023 Dec 6;10:1300330. doi: 10.3389/fnut.2023.1300330. eCollection 2023. Front Nutr. 2023. PMID: 38125729 Free PMC article.
-
The distinct transcriptome of virulence-associated phylogenetic group B2 Escherichia coli.Microbiol Spectr. 2023 Sep 19;11(5):e0208523. doi: 10.1128/spectrum.02085-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37724859 Free PMC article.
-
An Overview of Selected Bacterial Infections in Cancer, Their Virulence Factors, and Some Aspects of Infection Management.Biology (Basel). 2023 Jul 5;12(7):963. doi: 10.3390/biology12070963. Biology (Basel). 2023. PMID: 37508393 Free PMC article. Review.
-
β-glucans: a potential source for maintaining gut microbiota and the immune system.Front Nutr. 2023 May 5;10:1143682. doi: 10.3389/fnut.2023.1143682. eCollection 2023. Front Nutr. 2023. PMID: 37215217 Free PMC article. Review.
References
-
- World Cancer Research Fund international. [http://www.wcrf.org/cancer_statistics/world_cancer_statistics.php]
-
- Di Francia R, Siesto RS, Valente D, Del Buono A, Pugliese S, Cecere S, Cavaliere C, Nasti G, Facchini G, Berretta M. Current strategies to minimize toxicity of oxaliplatin: selection of pharmacogenomic panel tests. Anticancer Drugs. 2013;24:1069–1078. doi: 10.1097/CAD.0000000000000002. - DOI - PubMed
-
- Rahman AU, Salajegheh A, Smith RA, Lam AK: BRAF Inhibitor Therapy for Melanoma, Thyroid and Colorectal Cancers: Development of Resistance and Future Prospects. Curr Cancer Drug Targets, in press., - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical